Clyra Medical Technologies
Douglas Morgan is an accomplished executive with extensive experience in operations, strategic consulting, and technology development across various sectors. Currently serving as Chief Operating Officer at Clyra Medical Technologies since July 2023, Morgan previously held roles including Advisory Board Member and Consultant at the same company from March 2019 to June 2023, where contributions focused on marketing communications and IP strategy. Additional leadership positions include Director at ImageWare Systems, Senior Consultant at JBA Enterprise, and Chief Strategy Officer at C-SAM, along with other advisory roles within technology and finance. Morgan holds a Master of Science in Computer Science and BioEngineering from Stanford University and a Bachelor of Science in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology.
This person is not in any teams
Clyra Medical Technologies
Clyra Medical Technologies, founded on our mission of “Make Lives Better”, is a healthcare company that develops and commercializes products designed to safely treat wound and skin infections and promote wound healing, while reducing the need for antibiotics. Clyra Medical Technologies products feature a potent and broad-spectrum antibacterial, antifungal & antiviral oxidation system. With no known acquired resistance capability we deliver it on demand and in a proper dose so that it is safe and effective.